In supporting the activity of the SORE6 reporter as a detector of SOX2 and OCT4 expression [11], SORE6+ prostate cancer cells expressed higher levels of SOX2 and OCT4 than SORE6− cells. The gene discussed is SOX2; the disease is prostate carcinoma.